DSGN EPS Estimates
Design Therapeutics, Inc.
$10.77
+$0.12(+1.13%)
32
Overall
60
Value
10
Tech
26
Quality
Market Cap
$689.67M
Volume
455.70K
52W Range
$6.68 - $17.25
Target Price
$20.71
DSGN EPS estimates: the consensus estimate for Design Therapeutics, Inc.'s current fiscal year is -$1.39 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
DSGN EPS Estimates
- EPS estimate, current quarter
- $-0.50
- EPS estimate, next quarter
- $-0.40
- EPS estimate, current year
- $-1.39
- EPS estimate, next year
- $-1.62
- EPS growth, 3-year
- -2.29%
| Fiscal year | EPS |
|---|---|
| 2025 | $-1.22 |
| 2024 | $-0.88 |
| 2023 | $-1.19 |
| 2022 | $-1.14 |
| 2021 | $-0.77 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | DSGN | $10.77 | +1.1% | 455.70K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Design Therapeutics, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW